Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 7, Number 13, 2001

Book Reviews

Preface
pp. i-ii(2)
Authors: Hill, B.T.; Fahy, J.

Favourites:
ADD

Reviews

Physiochemical Aspects of Tubulin-Interacting Antimitotic Drugs
pp. 1213-1228(16)
Authors: Correia, J.J.; Lobert, S.

Favourites:
ADD
Favourites:
ADD

Preclinical Evaluation of New Taxoids
pp. 1251-1257(7)
Author: Bissery, M.

Favourites:
ADD

Cryptophycins: A Novel Class of Potent Antimitotic Antitumor Depsipeptides
pp. 1259-1276(18)
Authors: Shih, C.; Teicher, B.A.

Favourites:
ADD

The Epothilones, Eleutherobins, and Related Types of Molecules
pp. 1277-1290(14)
Authors: Stachel, S.J.; Biswas, K.; Danishefsky, S.J.

Favourites:
ADD

Spongistatins as Tubulin Targeting Agents
pp. 1291-1296(6)
Authors: Uckun, F.M.; Mao, C.; jan, S.; Huang, H.; Vassilev, A.O.; Navara, C.S.; Narla, R.K.

Favourites:
ADD

Epilogue
pp. 1297-1301(5)
Authors: Fahy, J.; Hill, B.T.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content